Navigation Links
Boston Scientific Announces Results for Fourth Quarter and Year Ended December 31, 2007
Date:2/4/2008

AP RESULTS OF OPERATIONS

(Unaudited)

Three Months Ended

December 31,

In millions, except per share data 2007 2006

Net sales $2,152 $2,065

Cost of products sold 635 526

Gross profit 1,517 1,539

Operating expenses

Selling, general and administrative expenses 704 758

Research and development expenses 256 267

Royalty expense 51 54

Amortization expense 174 174

Purchased research and development 13 2

Restructuring charges 176

Litigation-related charges 365

Loss on assets held for sale 208

1,947 1,255

Operating (loss) income (430) 284

Other income (expense):

Interest expense (137) (144)

Other, net (29) 29

(Loss) income before income taxes (596) 169

Income tax benefit (138) (108)

Net (loss) income $(458) $277

Net (loss) income per common share -

assuming dilution $(0.31) $0.19

Weighted average shares outstanding -

assuming dilution 1,490.8 1,493.6


'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. Boston Scientific to Participate in Merrill Lynch Conference
2. CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium
3. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
4. Boston Scientific Completes Sale of Auditory Business and Drug Pump Development Program
5. Boston Scientific Announces Results for Third Quarter Ended September 30, 2007
6. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
7. The 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Nov. 2-6
8. Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator
9. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
10. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
11. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... --  HX360 today announced that sixteen companies have ... Challenge competition. These companies, selected from a field ... one of four finalists to present their solutions live ... venture capitalists during the Innovation Challenge event. ... 2015 HIMSS Annual Conference & Exhibition, McCormick Place in ...
(Date:3/5/2015)... 2015 Bi-Biomics today announced a ... stain additive. The improvement in histological quality provided ... present in all daughter cells. , After processing ... was analyzed at 1000-1600x using light microscopy. ... in all daughter cells displayed predominant binary features ...
(Date:3/5/2015)... DUBLIN , Mar. 05, 2015 Research and ... addition of the "Mature Biotech Outlook 2015: New ... to their offering. All biotech companies ... Celgene (CELG), in past year, have given a positive ... These companies have been able to select therapy/niche indication ...
(Date:3/5/2015)... 05, 2015 RMI ... chronic orthopedic conditions such as meniscal tears, ACL ... and joint pain due to degenerative conditions like ... orthopedic surgeries to promote better post-surgical outcomes. , ... nearly pain-free bone marrow harvesting with two complimentary ...
Breaking Biology Technology:HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 2HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 3HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 4Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 4Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 5
... March 11 Raven,biotechnologies, inc., a privately held ... antibody therapeutics (MAbs) for cancer,today announced that an ... has been accepted as a poster discussion presentation ... of Clinical Oncology (ASCO).,The presentation is scheduled for ...
... 19, 2008 at 8:00 a.m. Eastern Time, TROY, ... is scheduled to participate in the Cowen & Company ... 17-20, 2008 at the,Boston Marriott Copley Place in Boston, ... executive officer,will make a 30-minute presentation on Wednesday, March ...
... 11 PAREXEL International,Corporation (Nasdaq: PRXL ) ... Brothers 11th Annual Global Healthcare Conference in Miami, ... will be making a,formal presentation on PAREXEL at ... A live webcast of this presentation will be ...
Cached Biology Technology:Raven Announces RAV12 Phase 1/2a Study Results To Be Presented at ASCO 2Raven Announces RAV12 Phase 1/2a Study Results To Be Presented at ASCO 3Somanetics Corporation to Present at Cowen & Company 28th Annual Health Care Conference 2PAREXEL International to Present at Lehman Brothers 11th Annual Global Healthcare Conference 2
(Date:2/5/2015)... , Feb. 3, 2015 Despite ... demand from industries such as consumer electronics, automotive, ... for surface mount technology (SMT) screen printers. Innovations ... automatic control will push the adoption curve up. ... remain steady as glue dispensers are indispensable in ...
(Date:1/22/2015)... MELBOURNE, Fla. , Jan. 13, 2015  Today, ... wearable technology, launched its crowdfunding campaign on Fundable, ... accelerate the build of production capacity to meet ... Photo - http://photos.prnewswire.com/prnh/20150113/168790 ...
(Date:1/22/2015)... , Jan. 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... commerce market, reports on the recent success of the Wocket™ smart wallet ... Wocket smart wallet was named as one of the "11 Hot ... "5 Best Products Launched At CES So Far" by Newseveryday.com and "The ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3
... Depression is the leading cause of disability with ... disease. In addition to debilitating consequences on mental health, ... heart disease, and conversely heart disease increases the risk ... by the year 2020 heart disease and depression will ...
... newly associated nine genetic regions with a rare autoimmune ... (PSC). This brings the total number of genetic regions ... per cent of people who suffer from PSC also ... of the newly associated genetic regions were shared with ...
... the number one killer in the U.S. for several decades. ... here. Obesity is a risk factor for both conditions and ... diabetics will die of cardiovascular disease. While this much ... still remains largely a mystery. Johnathan D. Tune, Ph.D., associate ...
Cached Biology News:Social stress and the inflamed brain 2Genetics defines a distinct liver disease 2Genetics defines a distinct liver disease 3Indiana University associate professor earns APS's Henry Pickering Bowditch Award 2Indiana University associate professor earns APS's Henry Pickering Bowditch Award 3
Homo sapiens palladin...
Request Info...
IgD Chain C (AMS 9.1)...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: